Rigel Pharmaceuticals (RIGL) Operating Leases (2019 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly Operating Leases came in at $228000.0 in Q1 2026, down 73.61% year-on-year from $864000.0 in Q1 2025, and down 42.28% quarter-over-quarter from $395000.0 in Q4 2025.
Rigel Pharmaceuticals (RIGL) Operating Leases (2019 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $228000.0 for Q1 2026.
- On a quarterly basis, Operating Leases fell 73.61% year-over-year to $228000.0 in Q1 2026; TTM through Mar 2026 was $228000.0, a 73.61% decrease from a year earlier, with the FY2025 full-year figure at $395000.0, changed N/A from the prior year.
- Operating Leases declined to $228000.0 in Q1 2026 per RIGL's latest filing, from $395000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $8.3 million in Q1 2022 and bottomed at $100000.0 in Q1 2024.
- The 5-year median for Operating Leases is $592000.0 (2023), against an average of $1.2 million.
- Across the five-year window, Operating Leases tumbled 90.34% in 2023 and soared 764.0% in 2025, its largest moves.
- Year by year, Operating Leases stood at $972000.0 in 2022, then sank by 70.68% to $285000.0 in 2023, then tumbled by 64.91% to $100000.0 in 2024, then surged by 295.0% to $395000.0 in 2025, then sank by 42.28% to $228000.0 in 2026.
- Per Business Quant, the three latest RIGL Operating Leases figures stand at $228000.0 (Q1 2026), $395000.0 (Q4 2025), and $556000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | 556,000.00 |
| Jun 30, 2025 | 714,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 285,000.00 |
| Sep 30, 2023 | 466,000.00 |
| Jun 30, 2023 | 628,000.00 |
| Mar 31, 2023 | 802,000.00 |
| Dec 31, 2022 | 972,000.00 |
| Mar 31, 2022 | 8.30 Mn |
| Dec 31, 2021 | 759,000.00 |
| Sep 30, 2021 | 3.31 Mn |
| Jun 30, 2021 | 15.10 Mn |
| Mar 31, 2021 | 8.30 Mn |
| Dec 31, 2020 | 19.30 Mn |
| Sep 30, 2020 | 12.93 Mn |
| Jun 30, 2020 | 15.25 Mn |
| Mar 31, 2020 | 17.31 Mn |